-+ 0.00%
-+ 0.00%
-+ 0.00%

Reviva Pharmaceuticals Q2 EPS $(0.19) Beats $(0.39) Estimate

Benzinga·08/12/2026 22:00:32
Listen to the news
Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.39) by 50 percent. This is a 92.08 percent increase over losses of $(2.40) per share from the same period last year.